Neuralia TMS Offers Innovative Tinnitus Treatment in Perth, WA

Australia, 16th Oct 2024, Neuralia TMS has introduced an innovative approach to tinnitus treatment at its Perth clinic, offering a new method for managing the condition. The treatment, based on Transcranial Magnetic Stimulation (TMS), is a non-invasive option that has been applied to a range of neurological conditions, including depression, anxiety, and obsessive-compulsive disorder. TMS is now being utilised to help alleviate the symptoms of tinnitus.

Neuralia TMS Offers Innovative Tinnitus Treatment in Perth, WA

Tinnitus, often experienced as a persistent ringing or buzzing in the ears, can severely affect an individual’s daily life, interfering with concentration, sleep, and overall well-being. Existing treatments, including sound therapy and medication, have shown limited effectiveness for many people. TMS has emerged as a promising alternative for individuals who have not found relief through conventional methods.

Dr Shanek Wick, Director of Neuralia TMS, commented on the significance of this new treatment. “Research into the application of TMS for tinnitus is producing encouraging results, particularly for those who have not responded to standard treatments. The availability of this therapy in Perth provides an important option for patients looking for relief from the effects of tinnitus,” said Dr Wick.

The process involves the use of magnetic pulses to target the brain’s auditory cortex, which plays a key role in tinnitus. By stimulating this area, TMS promotes neuroplasticity—the brain’s ability to form new neural connections. This can help reduce the perception of phantom sounds associated with tinnitus. The treatment is non-invasive and typically well-tolerated, providing a safer option compared to more invasive interventions.

While TMS as a treatment for tinnitus is still relatively new, early studies and clinical trials have demonstrated its potential to provide relief. The therapy’s effectiveness varies depending on the individual, but interest in TMS continues to grow among both patients and healthcare professionals. Neuralia TMS is one of the few clinics in Perth currently offering this treatment, aligning with its commitment to providing cutting-edge neurological care.

Neuralia TMS Offers Innovative Tinnitus Treatment in Perth, WA

Dr Wick noted that the clinic is focused on staying at the forefront of advancements in brain health. “The future of neurological treatments is shifting towards therapies that encourage the brain’s natural ability to heal. Techniques like TMS are leading this change, and there is optimism about further developments in this area. Neuralia TMS aims to continue expanding treatment options as research evolves.”

The clinic is now accepting patients for tinnitus consultations. Initial assessments are designed to determine whether TMS is an appropriate option based on each patient’s specific condition. For those eligible, the treatment typically involves several sessions over a few weeks, with each session lasting between 30 and 40 minutes.

Neuralia TMS is recognised for its evidence-based treatment of mental and neurological conditions. With the introduction of TMS for tinnitus, the clinic is furthering its mission to provide patients with access to the latest in medical advancements.

For more information on the tinnitus treatment or to schedule a consultation, contact Neuralia TMS at 08 6230 3996 or via email at info@neuralia.com.au.

Media Contact

Organization: Neuralia TMS

Contact
Person:
Dr Shanek Wick

Website:

https://www.neuraliatms.com.au/

Email:

info@neuralia.com.au

Contact Number: 61862303996

Country:Australia

The post Neuralia TMS Offers Innovative Tinnitus Treatment in Perth, WA appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Getfincorp journalist was involved in the writing and production of this article.